DT Form 4: Director Michael Capone vested 3,981 RSUs and received 4,111-new RSUs
Rhea-AI Filing Summary
Dynatrace director Michael L. Capone reported insider equity changes on Form 4. The filing shows certain unvested time-based restricted stock units (RSUs) previously reported in Table I were moved to Table II as derivative securities. A decrease of 3,981 common shares reflects RSUs reclassified; separately, 3,981 RSUs vested on 08/20/2025 and were reported as settled, and a new grant of 4,111 RSUs was reported that will vest on the earlier of the one-year anniversary of grant or the 2026 Annual Meeting, subject to continued service. The Form is signed by power of attorney on 08/21/2025.
Positive
- Scheduled vesting occurred: 3,981 RSUs vested on 08/20/2025, fulfilling a prior grant condition
- New director equity grant: 4,111 RSUs were granted with one-year/meeting-based vesting, supporting continued alignment with shareholders
- Clear SEC disclosure: Movement of RSUs between tables and vesting details were explicitly reported, meeting Section 16 transparency
Negative
- None.
Insights
TL;DR: Routine director RSU vesting and a modest follow-on grant; no cash sales or purchases reported.
The filing documents administrative movement of previously reported time-based RSUs into the derivative securities table, the vesting/settlement of 3,981 RSUs on 08/20/2025, and a new grant of 4,111 RSUs subject to one-year or meeting-based vesting and continued service. There are no reported open-market purchases or sales, no option exercises, and no cash proceeds, so immediate balance-sheet or liquidity implications for the issuer are minimal. For investors, this is a routine compensation and governance disclosure rather than a material corporate event.
TL;DR: Disclosure aligns with standard director compensation and SEC Section 16 reporting requirements.
The report clarifies treatment of time-based RSUs previously reported in Table I by moving them to Table II as derivative securities and records vesting and a subsequent grant with typical service-based vesting conditions tied to the annual meeting schedule. Signing by a power of attorney is noted and permissible. This appears to be routine governance transparency about equity awards to a director and does not indicate a change in control, executive departure, or extraordinary governance action.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 3,981 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 4,111 | $0.00 | -- |
| Exercise | Common Stock | 3,981 | $0.00 | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- This Form 4 reports the moving of unvested time-based restricted stock units ("RSUs") previously reported in Table I to Table II in addition to the transactions reflected herein. Reflects a decrease of 3,981 shares of the Issuer's Common Stock representing unvested RSUs that were previously reported in Table I and are being reported in Table II of this Form 4 as derivative securities. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs do not expire. They either vest or are cancelled prior to the vesting date. As previously reported on August 27, 2024, these RSUs were granted on August 23, 2024. 100% of the RSUs granted vested on August 20, 2025, which was the earlier of the one year anniversary of the date of grant (August 23, 2025) and the date of the Issuer's 2025 Annual Meeting of Stockholders (which was held on August 20, 2025). Represents the grant of RSUs. 100% of the RSUs granted will vest on the earlier of the one year anniversary of the date of grant (August 20, 2026) and the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director of the Issuer on the applicable vesting date.
